Literature DB >> 1486720

Pyoderma faciale in a patient with Crohn's disease.

P M McHenry1, M Hudson, L M Smart, J A Rennie, N A Mowat, M I White.   

Abstract

We wish to report the progress of a patient with pyoderma faciale and Crohn's disease. The patient is interesting in that on two occasions the relapse in her skin condition coincided with the introduction of non-steroidal anti-inflammatory drugs. Therapy with isotretinoin was effective and well tolerated.

Entities:  

Mesh:

Year:  1992        PMID: 1486720     DOI: 10.1111/j.1365-2230.1992.tb00262.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  5 in total

1.  Use of oral isotretinoin in the management of rosacea.

Authors:  Hyunhee Park; James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2011-09

Review 2.  Review.

Authors:  Vikas Pabby; Robert Burakoff
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-08

3.  Successful treatment of localized pyoderma faciale in a patient with Crohn's disease.

Authors:  Sanam Razeghi; Christian R Halvorson; Anthony A Gaspari; Raymond K Cross
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-08

4.  [Rosacea fulminans, pyostomatitis and pyovulvitis in Crohn's disease: dapsone as key factor in combination therapy].

Authors:  M Gatzka; M Simon; G Schuler; M Lüftl
Journal:  Hautarzt       Date:  2006-10       Impact factor: 0.751

Review 5.  A causal association between isotretinoin and inflammatory bowel disease has yet to be established.

Authors:  Seth D Crockett; Ajay Gulati; Robert S Sandler; Michael D Kappelman
Journal:  Am J Gastroenterol       Date:  2009-10       Impact factor: 10.864

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.